Form 4: MACOM Director Susan Ocampo Sells Shares in Multiple Transactions

Sentiment:

SEC Form 4


Director Susan Ocampo of MACOM Technology Solutions Holdings sold a significant number of shares held in trust for her children over several days in November 2024.

Summary

  • Susan Ocampo, a director at MACOM Technology Solutions Holdings, sold a total of 158,969 shares of common stock between November 13th and November 15th, 2024.
  • The sales were executed through trusts established for her children.
  • The shares were sold at varying prices, ranging from $123.03 to $130.50 per share.
  • The transactions resulted in a decrease in her indirect beneficial ownership of MACOM shares, from 6,046,676 to 5,914,008 shares held in trust for her children.
  • Additionally, she holds 6,796,685 shares through the Ocampo Family Trust and 2,138 shares directly.

Sentiment

Score: 4

Explanation: The document details a significant sale of shares by a director, which could be viewed negatively by the market, but it is not an unusual event. The sentiment is therefore slightly negative.

Negatives

  • The director's sale of a significant number of shares could be interpreted negatively by the market.

Risks

  • Large sales by insiders can sometimes signal a lack of confidence in the company's future prospects.
  • The market may react negatively to the news of the director's share sales.

Industry Context

Insider trading activity is closely monitored by investors as it can provide insights into management's perspective on the company's valuation and future prospects. This activity is not unusual but is always closely watched.

Comparison to Industry Standards

  • It is common for directors and officers to trade shares of their company, but the size and timing of these transactions are often scrutinized.
  • Comparable companies in the technology sector also see similar insider trading activity, but the impact on the stock price varies depending on the company's performance and market sentiment.

Stakeholder Impact

  • Shareholders may react to the news of the director's share sales, potentially impacting the stock price.
  • The sales do not directly impact employees, customers, or suppliers.

Key Dates

DateDescription
11/13/2024First day of reported share sales by Susan Ocampo.
11/14/2024Second day of reported share sales by Susan Ocampo.
11/15/2024Third and final day of reported share sales by Susan Ocampo.

Keywords

insider trading, share sales, beneficial ownership, director, MACOM, MTSI, stock transactions

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.